• Study on the Effectiveness and Safety of RO7434656 for Patients with Primary IgA Nephropathy at High Risk of Progression

    Not recruiting

    3 1 1
    Investigated Drugs:
    Czechia France Germany Greece Italy Poland +1

  • Study of Futibatinib for Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Poland Portugal Spain

  • Study Comparing Ibrutinib and Venetoclax with Chlorambucil and Obinutuzumab for First-line Treatment in Patients with Chronic Lymphocytic Leukemia

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark France The Netherlands Poland +2

  • Study on the Effectiveness of Alteplase as an Add-On to Mechanical Thrombectomy for Patients with Acute Ischemic Stroke

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study of HST-1011 Alone and with Cemiplimab for Patients with Advanced Solid Tumors Not Responding to Standard Treatments

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on the Safety and Effects of Forimtamig, Tocilizumab, and Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    Denmark France Germany Italy Spain

  • Study on BP1.4979 for Treating Binge Eating Disorder in Women with Moderate to Severe Symptoms

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    France Spain

  • Study of Sacituzumab Govitecan for Patients with Advanced Esophagogastric Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany

  • Study on Valbenazine for Treating Dyskinesia in Children and Adults with Cerebral Palsy

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Italy Poland Portugal Spain

  • Study Comparing MK-7684A and Pembrolizumab for Patients with PD-L1 Positive Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Hungary Romania

powered by